History

Gustav Pütter founded MEDICE in 1949 - after the second World War at a time when the British had asked him to pick up medications from Leverkusen and distribute them in the rural regions. Handicapped by spinal tubercolosis he was dedicated to study medicine and to develop his own remedies.

Upon its foundation in 1949 the company initially manufactured and marketed preparations for skin diseases, indigestion and hepatic metabolism.

When the founder died in 1977, his son Dr. med. Sigurd Pütter took over. ICH-guidelines had to be implemented, pharmaceutical development structured, the range of preparations expanded and marketing activities intensified.

In 2001, Dr. med. Katja Pütter-Ammer, daughter of Dr. Sigurd Pütter, joined the executive board of MEDICE, followed by Dr. med. Dr. oec. Richard Ammer in 2003. New pharmaceutical developments and product launches have led to internal growth, strategic acquisitions and a new structure of the company have strengthed MEDICE`s position in the marekt. Today, MEDICE is ranked #50 in Germany among 1024 phamaceutical firms, is market leader in child adolescent psychiatry; has a leading position in renal care as well as the secondary market. In the OTC-segment, MEDICE is ranked among the top 15 players.

In recent years, MEDICE has grown internationally, offering a pan-European distribution network and has strenghtened its presence in over 60 countries.

Milestones:

1949 Foundation
1953 Launch of the homeopathic complex preparation
for cough & cold "Meditonsin"
1963 Launch of re-vitalizing injection "Medivitan" in a double-chamber ready-to-use syringe
2005 Focusing in ADHD treatment - Launch of in-house developed and patented "Medikinet retard" / "Medikinet XL"
2006 Acquisition of Rentschler Arzenimittel GmbH with several OTC brands incl. "Soventol", "Dorithricin", "Tannacomp"
2007 Launch of the first European approved biosimilar erythropoietin "Abseamed"
2008 Forcing of Internationalization
2009 Expanding the portfolio in renal care (anemia treatment) with the first generic Iron sucrose "Fermed"
2010 Acquisition of Fagus (orthomolecular medicine)
2011 Launch of "Medikinet adult" (for adult ADHD)

With a 2-digit continous annual growth rate over the last five years MEDICE has grown to 400 employees and generates a turnover of approximately € 140 million.